Here are relevant reports on : green-energy-funding-and-global-market-research

  • The manufactured soils market is projected to reach USD 7.75 Billion by 2021, at a CAGR of 6.7% from 2016 to 2021. The growth of this market is attributed to the increasing demand for organic products, the increasing global population, improved yield & productivity, and increasing trend towards modern farming practices such as controlled agriculture and urban farming. Increase in demand for organic foods, swift growth in the urban farming techniques, increased demand for horticulture along with the promotion and aid by government agencies have fueled the usage of soil blends & mixes among the modern agricultural practices.

    • Published: May 2016
    • Price: $ 4950
    • TOC Available:
  • The market size for oxygenated solvents is estimated to grow from USD 22.28 Billion in 2017 to USD 32.27 Billion by 2022, at a CAGR of 7.8%. The growth is driven by the increased demand from applications such as paints & coatings, pharmaceuticals, lubricants, crop protection, and personal care. Key companies profiled in this research report on the oxygenated solvents market include BASF (Germany), The Dow Chemical Company (U.S.), OXEA (Germany), Royal Dutch Shell (Netherlands), ExxonMobil (U.S.), LyondellBasell (Netherlands), Eastman Chemical Company (U.S.), SINOPEC (China), and Petronas (Malaysia).

    • Published: November 2017
    • Price: $ 4950
    • TOC Available:
  • The Seaweed protein market size is projected to reach USD 1131 million by 2027, at a CAGR of 14.1% during the forecast period. The key players in this market include CP Kelco U.S., Inc. (US), Algaia (France), Algea (Norway), Qingdao Gather Great Ocean Algae Industry Group Co, Ltd (China), Qingdao Brightmoon Seaweed Co Group Co. Ltd (China), Cargill Incorporated (US) Gelymar SA (Chile), Ceamsa (Spain), BASF (Germany), Irish Seaweed (Ireland), Dupont Nutrition and Biosciences (US), Compo Expert Group (Germany), Beijing Leili Agricultural Co, Ltd (China), Groupe Roullier (France), Acadian Seaplants (Canada). These players in this market are focusing on increasing their presence through agreements and collaborations. These companies have a strong presence in North America, Asia Pacific and Europe. They also have manufacturing facilities along with strong distribution networks across these regions.

    • Published: May 2022
    • Price: $ 4950
    • TOC Available:
  • According to MarketsandMarkets, the seaweed cultivation market is projected to reach USD 30.2 billion by 2025, recording a CAGR of 12.6% during the forecast period, This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Cargill, Incorporated (US), DuPont (US), Groupe Roullier (France), CP Kelco U.S., Inc. (US), Acadian Seaplants (US), Qingdao Gather Great Ocean Algae Industry Group (China), Qingdao Seawin Biotech Group Co. Ltd. (China), Qingdao Bright Moon Seaweed Group Co. (China), Seaweed Energy Solutions AS (Norway), The Seaweed Company (Netherlands), Algea (Norway), Seasol (Australia), Gelymar (Chile), Algaia (France), CEAMSA (Spain), COMPO EXPERT (Germany), Leili (China), Irish Seaweeds (Ireland) and AtSeaNova (Belgium).

    • Published: October 2020
    • Price: $ 4950
    • TOC Available:
  • The report provides profiles of all major companies operating in the advanced manufacturing automation process market. Furthermore, the report includes the competitive landscape of key market players, which provides a detailed account of the growth strategies adopted by players in the advanced manufacturing automation process market. The report also covers the entire value chain for the market, right from research and product development to the end user. Along with the value chain, this report also provides an in-depth view on the technology, industry, and geographic analysis of the advanced manufacturing automation process market.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • The growth of the Lithium cobalt oxide market is attributed to the increasing demand for lithium-ion batteries, which are used in a variety of applications, such as electric vehicles, consumer electronics, and energy storage. Lithium cobalt oxide is a key component of lithium-ion batteries, as it provides high energy density and long cycle life. The increasing demand for electric vehicles is a major driver for the growth of the lithium cobalt oxide market. The growth of the electric vehicle market is being driven by government regulations, rising environmental concerns, and declining battery prices.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • Direct conjugated antibodies are widely utilized in research and diagnosis, encompassing disciplines like immunology, cancer, and neuroscience. Direct conjugated antibodies are more in demand as a result of the increased prevalence of chronic diseases, rising R&D expenditures, and the requirement for precise diagnostics.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:

Records 41 to 50 of 50

DMCA.com Protection Status